Rock Springs Capital Management LP Q1 2019 Filing

Filed May 15, 2019

Portfolio Value

$2.6B

Holdings

131

Report Date

Q1 2019

Filing Type

13F-HR

All Holdings (131 positions)

StockValue
$6.1M
RYTMRHYTHM PHARMACEUTICALS INC
$5.9M
MOMENTA PHARMACEUTICALS INC
$5.8M
ELVANTHEM INC
$5.7M
BCRXBIOCRYST PHARMACEUTICALS
$5.7M
ARDXARDELYX INC
$5.6M
MGNXMACROGENICS INC
$5.4M
ALDER BIOPHARMACEUTICALS INC
$4.8M
CGENCOMPUGEN LTD
$4.6M
MEDICINES CO
$4.2M
NABRIVA THERAPEUTICS PLC
$3.9M
CORREVIO PHARMA CORP
$3.8M
ADAPYADAPTIMMUNE THERAPEUTICS PLC
$3.4M
CHIASMA INC
$3.4M
MEDICINES CO
$3.0M
DVAXDYNAVAX TECHNOLOGIES CORP
$2.8M
RESTORBIO INC
$2.7M
PARATEK PHARMACEUTICALS INC
$2.4M
ARVNARVINAS INC
$2.2M
NVROEURNEVRO CORP
$2.2M
NVAXNOVAVAX INC
$1.8M
LA JOLLA PHARMACEUTICAL CO
$1.8M
CRVSCORVUS PHARMACEUTICALS INC
$1.6M
THERAVANCE BIOPHARMA INC
$1.5M
KLDOKALEIDO BIOSCIENCES INC
$1.5M
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC
$1.4M
RADIUS HEALTH INC
$1.2M
PACIRA PHARMACEUTICALS INC
$987K
DERMIRA INC
$888K
SLDBSOLID BIOSCIENCES INC
$552K
PROTEOSTASIS THERAPEUTICS IN
$504K
PreviousPage 2 of 2